Page 588«..1020..587588589590..600610..»

Biotechnology Recognized for contribution to renewable energy. – ThomasNet Industrial News Room (press release)

By Dr. Matthew Watson

Biotechnology Recognized for contribution to renewable energy.
ThomasNet Industrial News Room (press release)
June 28, 2013 - BIO applauded President Barack Obama's recognition of contributions made by biotechnology to design of new biofuels and to agricultural productivity in the President's Climate Action Plan. BIO President and CEO Jim Greenwood ...
BIO Applauds Legislation That Levels the Playing Field for Renewable ChemicalsThe Herald | HeraldOnline.com

all 2 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHDkE5PDOeswb1T7b3r6kJQyY40sA&url=http://news.thomasnet.com/companystory/Biotechnology-Recognized-for-contribution-to-renewable-energy-20010655

To Read More: Biotechnology Recognized for contribution to renewable energy. – ThomasNet Industrial News Room (press release)
categoriaUncategorized commentoComments Off on Biotechnology Recognized for contribution to renewable energy. – ThomasNet Industrial News Room (press release) | dataJune 30th, 2013
Read All

A joint campaign against GM crops, Biotechnology Bill – The Hindu

By Dr. Matthew Watson


The Hindu
A joint campaign against GM crops, Biotechnology Bill
The Hindu
Cutting across party lines, several political leaders participated on Tuesday in a joint campaign with civil society groups and farmers' organisations against Genetically Modified crops and the Biotechnology Regulatory Authority of India (BRAI) Bill at ...

and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEk_M5nOsbdxlmpuKqN-QK_K0o3aQ&url=http://www.thehindu.com/news/national/a-joint-campaign-against-gm-crops-biotechnology-bill/article4850719.ece

To Read More: A joint campaign against GM crops, Biotechnology Bill – The Hindu
categoriaUncategorized commentoComments Off on A joint campaign against GM crops, Biotechnology Bill – The Hindu | dataJune 30th, 2013
Read All

Prosensa Holding (RNA) IPO Opens Sharply Higher – StreetInsider.com (subscription)

By Dr. Matthew Watson

Prosensa Holding (RNA) IPO Opens Sharply Higher
StreetInsider.com (subscription)
Prosensa Holding is an innovative biotechnology company engaged in the discovery and development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company's primary focus is on rare ...
Prosensa leaps in 1st day of Nasdaq tradingThe Idaho Statesman

all 31 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFW63dhmZJa3SDxF7b7k92ytba9AA&url=http://www.streetinsider.com/Hot%2BIPOs/Prosensa%2BHolding%2B(RNA)%2BIPO%2BOpens%2BSharply%2BHigher/8459135.html

To Read More: Prosensa Holding (RNA) IPO Opens Sharply Higher – StreetInsider.com (subscription)
categoriaUncategorized commentoComments Off on Prosensa Holding (RNA) IPO Opens Sharply Higher – StreetInsider.com (subscription) | dataJune 30th, 2013
Read All

Puma Biotechnology to Join Russell 3000 Index – EON: Enhanced Online News (press release)

By Dr. Matthew Watson

Puma Biotechnology to Join Russell 3000 Index
EON: Enhanced Online News (press release)
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, is set to join the broad-market Russell 3000® Index following Russell Investments' annual reconstitution of its comprehensive set ...

and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGMe0_2rZw7lw7hFvtUsOr_G311ZA&url=http://eon.businesswire.com/news/eon/20130624005273/en/Puma-Biotechnology/Alan-Auerbach/PB272

To Read More: Puma Biotechnology to Join Russell 3000 Index – EON: Enhanced Online News (press release)
categoriaUncategorized commentoComments Off on Puma Biotechnology to Join Russell 3000 Index – EON: Enhanced Online News (press release) | dataJune 30th, 2013
Read All

OICR congratulates Dr. Thomas J. Hudson on being named to the Order of … – Canada NewsWire (press release)

By Dr. Matthew Watson

OICR congratulates Dr. Thomas J. Hudson on being named to the Order of ...
Canada NewsWire (press release)
In 2007, Dr. Hudson was appointed Professor in the Departments of Molecular Genetics and Medical Biophysics at the University of Toronto and he is a fellow of the Royal Society of Canada. He is editor-in-chief of the journal Human Genetics and has ...

and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNE7j84jrm2eBwg2yzfG7JNN6zi90w&url=http://www.newswire.ca/en/story/1192557/oicr-congratulates-dr-thomas-j-hudson-on-being-named-to-the-order-of-canada

To Read More: OICR congratulates Dr. Thomas J. Hudson on being named to the Order of … – Canada NewsWire (press release)
categoriaUncategorized commentoComments Off on OICR congratulates Dr. Thomas J. Hudson on being named to the Order of … – Canada NewsWire (press release) | dataJune 30th, 2013
Read All

Targeted viral therapy destroys breast cancer stem cells in preclinical … – EurekAlert (press release)

By Dr. Matthew Watson

Targeted viral therapy destroys breast cancer stem cells in preclinical ...
EurekAlert (press release)
... Endowed Chair in Cancer Research and co-leader of the Cancer Molecular Genetics program at VCU Massey, chairman of VCU School of Medicine's Department of Human and Molecular Genetics and director of the VCU Institute of Molecular Medicine.

and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFQ0vIz5lE95WiRo0EgGPHOSJBHjg&url=http://www.eurekalert.org/pub_releases/2013-06/vcu-tvt062413.php

To Read More: Targeted viral therapy destroys breast cancer stem cells in preclinical … – EurekAlert (press release)
categoriaUncategorized commentoComments Off on Targeted viral therapy destroys breast cancer stem cells in preclinical … – EurekAlert (press release) | dataJune 30th, 2013
Read All

Angelina Jolie, Medical College of Wisconsin and genome sequencing – The Business Journal of Milwaukee (blog)

By Dr. Matthew Watson

Angelina Jolie, Medical College of Wisconsin and genome sequencing
The Business Journal of Milwaukee (blog)
Howard Jacob, director of the college's Human and Molecular Genetics Center, told me. “That's really where we want to spend our time. There are plenty of places out there that have more firepower in the research arena than we do.” Rich Kirchen is The ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGDVFSgZvMQQ7Be-XnApSrl6ZFWZA&url=http://www.bizjournals.com/milwaukee/blog/2013/06/angelina-jolie-the-medical-college-of.html

To Read More: Angelina Jolie, Medical College of Wisconsin and genome sequencing – The Business Journal of Milwaukee (blog)
categoriaUncategorized commentoComments Off on Angelina Jolie, Medical College of Wisconsin and genome sequencing – The Business Journal of Milwaukee (blog) | dataJune 30th, 2013
Read All

Ami Ahern-Rindell Brings 20 Years of Experience to Undergraduate Research … – Newswise (press release)

By Dr. Matthew Watson

Ami Ahern-Rindell Brings 20 Years of Experience to Undergraduate Research ...
Newswise (press release)
She earned her M.S. and Ph.D. degrees in Genetics and Cell Biology from Washington State University and was an NIH Postdoctoral Fellow at the Center for Molecular Genetics at the University of California, San Diego. In 1992, she received her first ...

and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHiyaykpJjxzw0V5jyd8vQRQ_kMuA&url=http://www.newswise.com/articles/council-on-undergraduate-research-elects-new-president2?ret%3D/articles/list%26category%3Dlife%26page%3D1%26search%255Bstatus%255D%3D3%26search%255Bsort%255D%3Ddate%2Bdesc%26search%255Bsection%255D%3D30%26search%255Bhas_multimedia%255D%3D

To Read More: Ami Ahern-Rindell Brings 20 Years of Experience to Undergraduate Research … – Newswise (press release)
categoriaUncategorized commentoComments Off on Ami Ahern-Rindell Brings 20 Years of Experience to Undergraduate Research … – Newswise (press release) | dataJune 30th, 2013
Read All

RUSNANOPRIZE Award 2013 for Achievements in Nanomaterials and Surface … – AZoNano.com

By Dr. Matthew Watson


AZoNano.com
RUSNANOPRIZE Award 2013 for Achievements in Nanomaterials and Surface ...
AZoNano.com
Professor Lukyanov also had a successful business in the field of molecular genetics, and a score of 40 in the Hirsch Index at the same time. Anatoly Chubays, the RUSNANO CEO, presents the RUSNANOPRIZE Award to Prof. Sergey Lukyanov at the 2012 ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFqopuDRiQ2dFMunyGxc14X2sgY6w&url=http://www.azonano.com/article.aspx?ArticleID%3D3536

To Read More: RUSNANOPRIZE Award 2013 for Achievements in Nanomaterials and Surface … – AZoNano.com
categoriaUncategorized commentoComments Off on RUSNANOPRIZE Award 2013 for Achievements in Nanomaterials and Surface … – AZoNano.com | dataJune 30th, 2013
Read All

Student news published June 28, 2013 – Helena Independent Record

By Dr. Matthew Watson

Student news published June 28, 2013
Helena Independent Record
A 2010 graduate in cell biology, Harlen will use his fellowship to research molecular genetics in the department of genetics at Harvard Medical School. He would eventually like to become a professor. MedStart Summer Camp attendees. Kaitlin Kroll and ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGpYPihFHAv9v4bg227VhzZr6GQDQ&url=http://helenair.com/news/student_news/student-news-published-june/article_fc6b9264-dfb9-11e2-8433-001a4bcf887a.html

To Read More: Student news published June 28, 2013 – Helena Independent Record
categoriaUncategorized commentoComments Off on Student news published June 28, 2013 – Helena Independent Record | dataJune 30th, 2013
Read All

Cost of a Stem Cell Therapy? An Estimated $512,000

By Dr. Matthew Watson

The likely costs of potential stem cell therapies
and cures receive almost no attention in the media as well as
publicly from scientists and the biotech firms.
Usually any public discussion is
obliquely framed in the context of “reimbursement,” as if
industry is owed something instead of making a business decision
about what will make a profit. Euphemisms and jargon cloak unpleasant realities such as astronomical patient costs. But what reimbursement really involves are, in fact, pricing decisions and profit margins along with
lobbying campaigns for inclusion of
therapies in normal coverage of health insurance and Medicare
And today a singular figure – $512,000
for one stem cell treatment – appeared in the Wall Street
Journal
. The story by Kosaku Narioka and Phred Dvorak dealt
with what would be the first-ever human study of a treatment that
uses reprogrammed adult stem cells.
They reported that the study received
preliminary approval on Wednesday from a key panel of the Japan
Health Ministry.
The treatment involves a form of age-related macular
degeneration, which has also been targeted by the California stem
cell agency with different approaches.
Buried deep in the Wall Street Journal
article, with little other discussion, was this sentence:

“One eventual obstacle, even if tests
go well, could be cost: (Masayuki) Yamato (of Tokyo Women's Medical
University
) says initial estimates for the treatment run around ¥50
million ($512,000) per person."

The subject of costs for potential stem
cell treatments has rattled around in the background for years
without much deep public discussion. One reason is that high costs of
treatments are controversial and can trigger emotional debate.
Another reason is that it is very early in the therapy development
process and estimates are not likely to be entirely reliable.
A few years ago, however, the California stem
cell agency commissioned a study involving costs of stem cell therapies. The UC Berkeley report said,

“The cost impact of the therapy is
likely to be high, because of a therapy’s high cost per patient,
and the potentially large number of individuals who might benefit
from the therapy. This expense would put additional stress on
the Medicare and Medicaid budgets, cause private
insurance health premiums to increase, and create an incentive for
private plans to avoid covering individuals eligible for a therapy.”

The findings did not seem to be exactly
welcomed. The agency sat on the 2009 study for seven months until it
was uncovered by the California Stem Cell Report in April 2010. Then
the agency was careful to say that the study did not reflect the view
of CIRM management or board leadership.
Their wariness of being out in front on the issue could be well-advised. The pharmaceutical industry received some unpleasant attention this spring when more than 100 influential cancer specialists from more than 15 countries publicly denounced the cost of cancer drugs that exceed more than $100,000 a year.
Nonetheless pricing is critical
to both patient accessibility and therapy development. If companies
cannot make a profit on a possible therapy, it is virtually certain
not to appear in the marketplace.
While the subject remains in the
background, it does not mean there is a lack of interest. The copy of
the Berkeley stem cell cost study that was posted online by the California
Stem Cell Report has been read 11,701 times since it was made
available in April 2010 on scribd.com.
A copy of the study can be found below.

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/IObtHBtAe_E/cost-of-stem-cell-therapy-estimated.html

To Read More: Cost of a Stem Cell Therapy? An Estimated $512,000
categoriaStem Cell Therapy commentoComments Off on Cost of a Stem Cell Therapy? An Estimated $512,000 | dataJune 30th, 2013
Read All

Bluebird and Banking: Media Pluses for California Stem Cell Agency

By Dr. Matthew Watson

The California stem cell agency scored
a couple of favorable publicity points last week as the result of a
successful stock offering by an award recipient and another piece
about creation of a stem cell bank in Northern California.
The IPO by bluebird bio (the company's
preferred spelling) of Massachusetts was a big winner for the
company, raising millions of dollars more than anticipated.
The Boston Globe wrote,

“Shares of the Cambridge life
sciences company bluebird bio Inc. soared almost 60 percent on their
first day of trading (last) Wednesday, an impressive debut for a
business that endured years of stagnation and another encouraging
sign for the biotechnology industry.

“The local gene therapy company
raised $101 million in an initial public offering priced at $17 per
share, higher than the $14 to $16 estimated by investment bankers.
Bluebird shares closed at $26.91 per share on Wednesday.”

The stock continues to trade around $25
a share at the time of this writing, which is good news generally for
the biotech industry.
The company received a $9.4 million
award last fall from the $3 billion stem cell agency. The company has yet to receive any actual cash from the agency as both parties work
out final details of an agreement, a spokesman for the agency said
last week.
The stem cell agency touted the
successful IPO in a blog item by  that said,

“Bluebird Bio, one of the oldest
companies in the struggling gene therapy field, is having an
outstanding first day in the stock market today, and largely by
marrying its gene therapy technology with stem cell science. The
company’s financial milestone brings hope and excitement to both
fields.”

However, the news stories about the IPO
failed to mention the stem cell agency's involvement, which would
have been nice for the agency but was to be expected given the way
news is covered.
The story about the stem cell bank
appeared on Xconomy, an Internet news service dealing with
technology. Written by Bernadette Tansey, a former San Francisco
Chronicle
reporter, the piece dealt with the both business and science of stem cell banking. She wrote,

“One of the main goals of
California’s $3 billion stem cell research agency is to draw
companies into the state so they can vie for a share of the funding.

"With a recently funded $32 million
initiative, the California
Institute for Regenerative Medicine
(CIRM) has attracted two of
the biggest US players in stem cell banking to Novato, CA, to form
one of the largest biobanks of induced pluripotent stem cells (iPS
cells) in the world.”

The stem cell bank effort has become a
minor staple in recent news coverage of CIRM, surfacing in a number
of articles since the awards were approved. One of the reasons for that is that the project has a relatively straight-forward story line compared to many research efforts and the concept of "banking" is familiar to editors, writers and readers. 

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/6WeU6kIIs6E/bluebird-and-banking-media-pluses-for.html

To Read More: Bluebird and Banking: Media Pluses for California Stem Cell Agency
categoriaStem Cell Therapy commentoComments Off on Bluebird and Banking: Media Pluses for California Stem Cell Agency | dataJune 30th, 2013
Read All

Stem Cell Therapy Becomes More Widely Available | Video ABC News – Video

By daniellenierenberg


Stem Cell Therapy Becomes More Widely Available | Video ABC News
Beverly Hills Orthopedic surgeon Dr. Raj appeared on ABC #39;s Good Morning America to share the breatkthrough stem cell treatment that #39;s now available to weeken...

By: AHPRvideo

Continued here:
Stem Cell Therapy Becomes More Widely Available | Video ABC News - Video

To Read More: Stem Cell Therapy Becomes More Widely Available | Video ABC News – Video
categoriaUncategorized commentoComments Off on Stem Cell Therapy Becomes More Widely Available | Video ABC News – Video | dataJune 28th, 2013
Read All

Punto por Punto: Phil Medical Association, nagbabala sa iligal na pagsasagawa ng stem cell therapy – Video

By JoanneRUSSELL25


Punto por Punto: Phil Medical Association, nagbabala sa iligal na pagsasagawa ng stem cell therapy
MANILA - Punto por Punto host Anthony Taberna discusses the possible dangers of illegal stem cell therapy.

By: TheABSCBNNews

Read more:
Punto por Punto: Phil Medical Association, nagbabala sa iligal na pagsasagawa ng stem cell therapy - Video

To Read More: Punto por Punto: Phil Medical Association, nagbabala sa iligal na pagsasagawa ng stem cell therapy – Video
categoriaUncategorized commentoComments Off on Punto por Punto: Phil Medical Association, nagbabala sa iligal na pagsasagawa ng stem cell therapy – Video | dataJune 28th, 2013
Read All

63 year old stroke victim was greatly improved through stem cell therapy – Video

By daniellenierenberg


63 year old stroke victim was greatly improved through stem cell therapy

By: Gökhan Akdo #287;an

Read the original:
63 year old stroke victim was greatly improved through stem cell therapy - Video

To Read More: 63 year old stroke victim was greatly improved through stem cell therapy – Video
categoriaUncategorized commentoComments Off on 63 year old stroke victim was greatly improved through stem cell therapy – Video | dataJune 28th, 2013
Read All

Cell Therapy Catapult – World Stem Cells Regenerative Medicine Congress 2013 – Video

By raymumme


Cell Therapy Catapult - World Stem Cells Regenerative Medicine Congress 2013
We spoke with some of the sponsors at Europe #39;s largest stem cells and regenerative medicine industry conference. This is a three day congress that stages a s...

By: biopharmachannel

See more here:
Cell Therapy Catapult - World Stem Cells Regenerative Medicine Congress 2013 - Video

To Read More: Cell Therapy Catapult – World Stem Cells Regenerative Medicine Congress 2013 – Video
categoriaUncategorized commentoComments Off on Cell Therapy Catapult – World Stem Cells Regenerative Medicine Congress 2013 – Video | dataJune 28th, 2013
Read All

Foreign doctors behind illegal stem cell therapy – Video

By LizaAVILA


Foreign doctors behind illegal stem cell therapy
The Philippine Medical Association wants to go after foreign doctors who are reportedly conducting unauthorized stem cell procedures in the country.

By: TheABSCBNNews

Visit link:
Foreign doctors behind illegal stem cell therapy - Video

To Read More: Foreign doctors behind illegal stem cell therapy – Video
categoriaUncategorized commentoComments Off on Foreign doctors behind illegal stem cell therapy – Video | dataJune 28th, 2013
Read All

Paralyzed German Shepard Receives Revolutionary Stem Cell Therapy! – Video

By JoanneRUSSELL25


Paralyzed German Shepard Receives Revolutionary Stem Cell Therapy!

By: Stemlogix, LLC

See more here:
Paralyzed German Shepard Receives Revolutionary Stem Cell Therapy! - Video

To Read More: Paralyzed German Shepard Receives Revolutionary Stem Cell Therapy! – Video
categoriaUncategorized commentoComments Off on Paralyzed German Shepard Receives Revolutionary Stem Cell Therapy! – Video | dataJune 28th, 2013
Read All

DOH: Solons who died after stem cell therapy were sick

By LizaAVILA

MANILA - Two congressmen who died after undergoing stem cell therapy abroad were already sick before getting treatment, Health Secretary Enrique Ona said Tuesday.

Speaking to reporters, Ona refused to say if stem cell treatment caused the deaths of congressmen Erico Aumentado and Pedro Romualdo. Both lawmakers died of pneumonia.

"First hindi ko alam yun. Second, ang information that we got: It has nothing to do Ibig sabihin, they were already very sick bago nagpa-so-called stem call, baka sakali," he said in the interview.

On the other hand, the health secretary said clinics or hospitals in the Philippines offering stem cell treatments should be duly licensed by the Department of Health.

Dapat yung mga clinic or mga ospital na gumagawa noon kailangang mayroong license, approved ngayon ng DOH. Kaya iinspekyunin sila," he said.

House Speaker Sonny Belmonte earlier confirmed Aumentado and Romualdo had died after undergoing stem cell treatment in Germany last year. He clarified that it has not been established whether stem cell therapy was the cause of death.

Belmonte said that after having stem cell therapy, the 2 felt rejuvenated and may have exerted themselves during the last election campaign.

Belmonte said Aumentado even started walking around without a cane.

Aumentado's son, Aristotle, earlier said his father had leg thrombosis for which he had to undergo bifemoral bypass and stem cell therapy .

After stem cell therapy, his father started walking without a cane, and sometimes had low-blood sugar. However, he said they forgot to get him stem cell treatment for his father's pneumonia, which he had before the stem cell treatment in Germany last September.

Here is the original post:
DOH: Solons who died after stem cell therapy were sick

To Read More: DOH: Solons who died after stem cell therapy were sick
categoriaUncategorized commentoComments Off on DOH: Solons who died after stem cell therapy were sick | dataJune 28th, 2013
Read All

House seeks probe on stem-cell therapy link to solons’ deaths

By Sykes24Tracey

Should there be a law on stem cell therapy? The House of Representatives (HOR) has no idea. And for the sake of finding answer, House leaders intend to consult with medical experts about the issues surrounding the procedure. Speaker Feliciano Sonny Belmonte Jr. admits lawmakers need an expert opinion before they take any legislative action on reports about the negative effects of the expensive treatment. At this point, we have absolutely no basis to say that it was wrong (or) it wasnt wrong (or) it should be regulated, it should not be regulated, Belmonte said. Belmonte issued the statement after the Philippine Medical Association (PMA) said it is looking into the recent deaths of three politicians, who died after receiving xenogenic treatment in Germany. PMA president Dr. Leo Olarte said his group is still trying to find out whether politicians died due to their illness or due to hypersensitive reaction from animal-based stem cell treatments they received. On Monday, Belmonte revealed that Camiguin Rep. Pedro Romualdo underwent stem cell treatment in Germany before he died in April due to pneumonia. Incoming Bohol Rep. Aris Aumentado also admitted his father, the late Bohol Rep. Erico Aumentado, had undergone similar treatment in September before he died last Christmas, also due to pneumonia. We are still awaiting the word of the experts and the medical experts, not political experts on how, if anything, is demanded from us, Belmonte said. Olarte, who is the spokesperson of Philippine Society for Stem Cell Medicine, cited initial information that the politicians received stem cell therapy that used sheeps. He reiterated that receiving animal-based stem cell is dangerous because it may trigger complications such as graft versus host reaction. The expert advised Filipinos and public officials to choose autologous adult stem cell treatment, which is derived from the patients own blood, bone marrow or fat. Last March, the Department of Health (DOH) has restricted hospitals and other facilities from using genetically-altered cells and tissues of human in carrying out stem-cell therapy and treatments in the country. Health secretary Enrique Ona added their department also prohibits the use of umbilical cord, fat-derived human stem cells, and live animal stem cells for the conduct of the procedure locally.

ONA released Administrative Order (AO) 2013-0012, which seeks to ensure the safety of people who want to undergo human stem cell and cell-based therapies.

Excerpt from:
House seeks probe on stem-cell therapy link to solons' deaths

To Read More: House seeks probe on stem-cell therapy link to solons’ deaths
categoriaUncategorized commentoComments Off on House seeks probe on stem-cell therapy link to solons’ deaths | dataJune 28th, 2013
Read All

Page 588«..1020..587588589590..600610..»


Copyright :: 2025